TEL AVIV, Israel, March 7, 2024 /PRNewswire/ -- Arbe
Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in
Perception Radar Solutions, today announced financial results for
its fourth quarter and full year ended on December 31, 2023.
Key Q4 and 2023 Company Highlights:
- Arbe completed its chipset pre-production phase and is in the
final stages towards production ramp up in 2024. Following that,
Arbe Tier-1s announced they will
begin mass production of radar systems, based on the Arbe chipset,
starting with the Tier-1s in China.
- Radars based on Arbe's chipset were selected for five
perception projects with leading OEMs.
- Arbe received a second order from a leading Western truck
company, marking an important step towards a full commercial order.
- HiRain Technologies, a leading Chinese ADAS Tier-1 supplier,
announced that it will begin the mass production of
state-of-the-art 4D Imaging Radars, powered by Arbe's chipset, by
the end of 2024.
- Sensrad, one of Arbe's Tier-1s, announced significant customer
orders from companies across the globe for its radar systems based
on Arbe's chipset.
- Arbe's chipset is being evaluated by key players that
collectively account for more than a 40% share in the passenger
vehicle market. These companies' cumulative radar revenue is
projected to reach $7.5 billion by
the end of the decade.
- Although decision timelines were extended beyond the originally
forecasted end of 2023, Arbe's progress continues to stay on
course, and the company expects a positive result for the RFQs in
2024.
- In Q4, Arbe released the production version of its Radar
Processor, designed to be the strongest dedicated automotive radar
processing solution on the market.
- Arbe announced the availability of its production intent
chipset for use in mass manufacturing of Perception Radars. The
chipset meets the final Arbe specifications and is used for Tier 1
radar system production and for OEM development programs.
- Arbe is initiating a dual listing on the Tel Aviv Stock
Exchange (TASE), to enhance trading volume. Simultaneously, the
company is negotiating the issuance of bonds on TASE, to secure
working capital to support the predicted production ramp up in
2025.
"We are proud of our accomplishments in 2023, as our production
intent chipset has been successfully delivered, and is currently
undergoing rigorous automotive qualification processes towards mass
production. Our industry-leading radar solutions are not only
redefining road safety but also driving the hands-free revolution,"
said Kobi Marenko, Chief Executive
Officer. "Despite market delays resulting in extended decision
times, OEMs have expressed enthusiasm for our solutions. The
anticipation surrounding our offerings is high, and we expect to
announce substantial customer wins in 2024."
"In 2023, Arbe's Tier-1s achieved substantial progress in system
development, positioning the Tier-1s to enter the production and
commercial phases in 2024. Additionally, our strategic focus on
expanding our Total Addressable Market (TAM) by targeting
non-automotive sectors is proving successful. We foresee
accelerated technology adoption by several non-automotive players."
concluded Marenko.
Fourth Quarter and Full Year 2023 Financial
Highlights
Revenues for Q4 2023 were $0.35
million, compared to $0.15
million in Q4 2022. Full year 2023 revenues were
$1.5 million, a decrease from
$3.5 million in 2022. New orders for
the full year 2023 were $2.6 million.
Backlog as of December 31, 2023,
represents $1 million of orders.
Gross margin in Q4 2023 was a negative 54.5%, compared to a
negative gross margin of 45.6% in Q4 2022. Q4 2023 negative gross
margin resulted from low quarterly revenue with a fixed cost
portion and partial cost catch up from Q3'23. Gross margin for the
full year of 2023 was negative 2.6% compared to a positive 63.5% in
2022. Year over year gross margin reduction was primarily related
to economy of scale.
Operating expenses in Q4 2023 were $11.9
million, compared to $14.0
million in Q4 2022. Operating expenses for the full year of
2023 were $46.8 million, compared to
$50.0 million in 2022. The operating
expenses decrease was primarily a result of our advanced production
stage and the finalization of costs related to this bring-up.
Additionally, labor cost decreased mainly due to favorable exchange
rate and reduction in D&O insurance due to reduced rates. The
decrease was partially offset by an increase in non-cash
share-based compensation expenses.
Net loss in the fourth quarter of 2023 was $9.3 million compared to a net loss of
$11.1 million in the same period of
2022. Net loss for the full year of 2023 was $43.5 million compared to a net loss of
$40.5 million last year. 2023 Net
loss included financial income of $3.4
million compared to $7.2
million of financial income in 2022. 2023 financial income
resulted from interest deposits, favorable exchange rate
revaluations and warrants revaluation income.
Adjusted EBITDA in Q4 of 2023, a non-GAAP measurement which
excludes expenses for non-cash share-based compensation and
for non-recurring items, yielded a loss of ($8.2) million, compared with a loss of
($11.5) million in the fourth quarter
of 2022. Adjusted EBITDA for the full year of 2023 amounted to
($32.5) million, an improvement from
($38.0) million in 2022.
Balance Sheet & Liquidity
As of December 31, 2023, Arbe had
$28.6 million in cash and cash
equivalents and $15.4 million in
short term bank deposits with no debt.
Outlook
- Our goal of achieving 4 design-ins with automakers remains
unchanged, as we observe continued strong interest in our
market-leading offering.
- We have strengthened our positioning in all our RFQ
engagements, even though the OEMs have shifted their decision
timelines from late 2023 to 2024.
- The 2024 annual revenues are expected to be in line with those
of 2023, followed by revenue growth in 2025. These revenue
projections are based on the intention to be in full production in
the second half of 2024, as well as our decision to exclusively
focus on getting our chipset into production.
- We are committed to maintaining a strong and well-managed
balance sheet, focusing on cost-effectiveness and the ability to
fund our revenue growth. Adjusted EBITDA for 2024 is projected to
be in the range of ($30) million to
($36) million.
Conference Call & Webcast Details
Arbe will host a conference call and webcast today, March 7, 2024, at 8:30 am
ET. Speakers will include Kobi
Marenko, Chief Executive Officer, Co-Founder and Director,
and Karine Pinto-Flomenboim, Chief Financial Officer. We encourage
participants to pre-register for the conference call here. Callers
will receive a unique dial-in upon registration, which enables
immediate access to the call. Participants may pre-register at any
time, including up to and after the call start time.
The live call may be accessed via:
U.S. Toll Free: (833) 316-0562
International: (412) 317-5736
Israel Toll Free: (80)
921-2373
A telephonic replay of the conference call will be available
until March 21, 2024, following the
end of the conference call. To listen to the replay, please
dial:
U.S. Toll Free: (877) 344-7529
International: (412) 317-0088
Access ID: 7640562
A live webcast of the call can be accessed here or from
Arbe's Investor Relations website at
https://ir.arberobotics.com/news/ir-calendar. An archived webcast
of the conference call will also be made available on the website
following the call.
About Arbe
Arbe (Nasdaq: ARBE), a global leader in Perception Radar
Solutions, is spearheading a radar revolution, enabling truly safe
driver-assist systems today while paving the way to full
autonomous-driving. Arbe's radar technology is 100 times more
detailed than any other radar on the market and is a critical
sensor for L2+ and higher autonomy. The company is empowering
automakers, Tier-1 suppliers, autonomous ground vehicles,
commercial and industrial vehicles, and a wide array of safety
applications with advanced sensing and paradigm changing
perception. Arbe, a leader in the fast-growing automotive radar
market, is based in Tel Aviv,
Israel, and has offices in China, Germany, and the
United States.
Cautionary Note Regarding Forward-Looking Statements
This press release and the earnings call contain
"forward-looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, both as
amended by the Private Securities Litigation Reform Act of 1995.
The words "expect," "believe," "estimate," "intend," "plan,"
"anticipate," "may," "should," "strategy," "future," "will,"
"project," "potential" and similar expressions indicate
forward-looking statements. Forward-looking statements are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. The financial
results described in this press release are based on Arbe's
preliminary financial statements, which are subject to audit by the
Company's independent accounting firm and are subject to any
adjustments resulting from the completion of such audit. These
risks and uncertainties include, but are not limited to: (i) our
ability to generate firm orders from the Tier-1s who are
incorporating our chipset in the radar products they are marketing
to automobile manufacturers; (ii) the success of our Tier-1s to
market and sell product that are based on our chipset; (iii) our
ability to raise funds on terms that are acceptable and do not have
a negative impact on our stock price; (iv) the impact of Israel's
war with Hamas and any other hostilities on our business; (v)
decisions by Tier-1s and automakers not to do business with Israeli
suppliers; (vi) unanticipated delays or difficulties in connection
with the evaluation of Arbe's products in evaluation and test
programs; (vii) Arbe's ability to have products manufactured for it
by its third party supplier that meet Arbe's and its customers
quality standards and delivery requirements; (viii) Arbe's ability
to leverage its existing relationships and secure orders resulting
from the test programs; (xv) Arbe's ability to meet its projected
revenue level and its ability to operate profitably; (xv) Arbe's
ability to meet its timetable both to achieve full production
and to meet the delivery requirements of its customers; (xvi) the
development of safe autonomous vehicles that include Arbe's radar
systems; (xvii) Arbe's expectation that it will obtain orders
from Tier 1 suppliers and automakers that would build the radars
based on its Chipset solution; (xviii) the effect of inflation and
supply chain issues on Arbe's cost and its development schedule,
including Arbe's ability to obtain semiconductor products when
needed and at a reasonable price; (xix) Arbe's ability to price its
products in a manner to enable it to operate profitably; (xx)
Arbe's expectation that radars are crucial to the automotive
industry and in the not too distant future will be deployed in
nearly all new vehicles as a long range, cost-effective sensor with
the fewest environmental limitations; (xxi) Arbe's belief that the
Arbe Radar Chipset and Lynx Surround Imaging Radar herald a
breakthrough in radar technology that provide Tier 1 suppliers and
automakers with the ability to replace the current radars with an
advanced solution that meets the safety requirements of Euro-NCAP
and NHTSA for autonomous vehicles at all levels of autonomous
driving; (xxii) Arbe's ability to develop or have access to the
latest developments relating to radar and autonomous driving
vehicles; (xxiii) the ability of its Tier 1 customers to
successfully market radar systems using Arbe's radar to automobile
manufacturers; (xxiv) Arbe's ability to attract and retain highly
skilled personnel and senior management, including research and
development, sales and marketing personnel; (xxv) Arbe's ability to
develop and market products based on its radar technology for uses
outside of the automotive industry; (xxvi) accidents or bad press
resulting from accidents involving autonomous driving vehicles,
even those using radar products from other companies or based on
other technology and the effect of any accidents with vehicles
using Arbe's radar system; (xxvii) the failure of the markets for
Arbe's current or new technologies and products to materialize to
the extent or at the rate that Arbe expects; (xxviii) unexpected
delays or difficulties related to the development of Arbe's
technologies and products; (xxix) the effect of laws and changes in
laws that have an effect on the market for or the requirement for
autonomous vehicles; (xxx) Arbe's belief that an increased demand
for autonomous vehicles and the transition to mass production of
Level 2 and higher autonomous vehicles, requiring advanced systems
for automatically integrating vehicles in traffic and preventing
traffic accidents, are expected to increase the demand for products
in our field of activity; (xxxi) Arbe's belief that any requirement
on the part of insurance companies that radar systems be installed
as a condition for issuing insurance policies is expected to
increase the demand for Arbe's products; (xxxii) the effect of
COVID-19 and any new variants or any pandemics or multinational
epidemics and actions taken by governments, and industry to address
the effects of the pandemic and the corresponding macroeconomic
uncertainty including the effects of the decision of the government
of the People's Republic of China
to change from the zero-COVID policy; (xxxiii) changes or
inaccuracies in market projections; (xxxiv) changes in Arbe's
business strategy; as well as the risk and uncertainties described
in "Risk Factors," "Management's Discussion and Analysis of
Financial Condition and Results of Operations," "Cautionary Note
Regarding Forward-Looking Statements" and the additional risk
described in Arbe's Annual Report on Form 20-F, filed with the
Securities and Exchange Commission, or SEC, on March 31, 2022 and in Arbe's prospectus dated
June 22, 2022, which was filed by
Arbe with the SEC on June 23, 2022,
and its prospectus dated July 11,
2022, which was field by Arbe with the SEC on July 19, 2022, as well as other documents filed
by Arbe with the SEC. Accordingly, you are cautioned not to place
undue reliance on these forward-looking statements. Forward-looking
statements relate only to the date they were made, and Arbe does
not undertake any obligation to update forward-looking statements
to reflect events or circumstances after the date they were made
except as required by law or applicable regulation.
Information contained on, or that can be accessed through, our
website or any other website or any social media is expressly not
incorporated by reference into and is not a part of this press
release.
CONSOLIDATED BALANCE
SHEETS
|
(U.S. dollars in
thousands)
|
|
|
December 31,
2023
|
|
December 31,
2022
|
Current
Assets:
|
|
(Unaudited)
|
|
(Unaudited)
|
Cash and cash
equivalents
|
|
28,587
|
|
54,171
|
Restricted
cash
|
|
163
|
|
144
|
Short term Bank
deposits
|
|
15,402
|
|
400
|
Trade
receivable
|
|
1,258
|
|
2,202
|
Prepaid expenses and
other receivables
|
|
2,026
|
|
1,839
|
Total current
assets
|
|
47,436
|
|
58,756
|
|
|
|
|
|
Non-Current
Assets
|
|
|
|
|
Operating lease
right-of-use assets
|
|
1,740
|
|
465
|
Property and equipment,
net
|
|
1,309
|
|
1,609
|
Total non-current
assets
|
|
3,049
|
|
2,074
|
|
|
|
|
|
Total
assets
|
|
50,485
|
|
60,830
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Trade
payables
|
|
1,149
|
|
1,244
|
Operating lease
liabilities
|
|
436
|
|
364
|
Employees and payroll
accruals
|
|
2,916
|
|
2,861
|
Deferred
revenues
|
|
-
|
|
351
|
Accrued expenses and
other payables
|
|
1,710
|
|
5,609
|
Total current
liabilities
|
|
6,211
|
|
10,429
|
|
|
|
|
|
Long term
liabilities
|
|
|
|
|
Operating lease
liabilities
|
|
1,306
|
|
17
|
Warrant
liabilities
|
|
875
|
|
1,631
|
Total long-term
liabilities
|
|
2,181
|
|
1,648
|
|
|
|
|
|
SHAREHOLDERS'
EQUITY:
|
|
|
|
|
Ordinary
Shares
|
|
*)
|
|
*)
|
Additional paid-in
capital
|
|
245,733
|
|
208,893
|
Accumulated
deficit
|
|
(203,640)
|
|
(160,140)
|
Total shareholders'
equity
|
|
42,093
|
|
48,753
|
|
|
|
|
|
Total liabilities
and shareholders' equity
|
|
50,485
|
|
60,830
|
|
|
|
|
|
*) Represents less than
$1.
|
|
|
|
|
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
(U.S. dollars in
thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
|
December 31,
2023
|
|
December 31,
2022
|
|
December 31,
2023
|
|
December 31,
2022
|
|
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Revenues
|
|
347
|
|
149
|
|
1,470
|
|
3,517
|
|
Cost of
revenues
|
|
536
|
|
217
|
|
1,508
|
|
1,283
|
|
Gross Profit
(Loss)
|
|
(189)
|
|
(68)
|
|
(38)
|
|
2,234
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Expenses:
|
|
|
|
|
|
|
|
|
|
Research and
development, net
|
|
8,446
|
|
10,827
|
|
34,082
|
|
36,731
|
|
Sales and
marketing
|
|
1,528
|
|
1,194
|
|
5,194
|
|
4,621
|
|
General and
administrative
|
|
1,934
|
|
2,026
|
|
7,571
|
|
8,613
|
|
Total operating
expenses
|
|
11,908
|
|
14,047
|
|
46,847
|
|
49,965
|
|
|
|
|
|
|
|
|
|
|
|
Operating
loss
|
|
(12,097)
|
|
(14,115)
|
|
(46,885)
|
|
(47,731)
|
|
|
|
|
|
|
|
|
|
|
|
Financial income,
net
|
|
(2,812)
|
|
(3,004)
|
|
(3,385)
|
|
(7,237)
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
(9,285)
|
|
(11,111)
|
|
(43,500)
|
|
(40,494)
|
|
|
|
|
|
|
|
|
|
|
|
Basic net loss per
ordinary share
|
|
(0.12)
|
|
(0.17)
|
|
(0.60)
|
|
(0.64)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares
used in computing basic net loss per
ordinary share
|
|
77,837,624
|
|
63,940,247
|
|
72,021,520
|
|
63,489,983
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net loss per
ordinary share
|
|
(0.15)
|
|
(0.25)
|
|
(0.71)
|
|
(0.80)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares
used in computing diluted net loss per
ordinary share
|
|
63,226,491
|
|
58,860,661
|
|
62,390,302
|
|
60,960,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
(U.S. dollars in
thousands)
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
|
December 31,
2023
|
|
December 31,
2022
|
|
December 31,
2023
|
|
December 31,
2022
|
|
Cash flows from
operating activities:
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Net
Loss
|
|
(9,285)
|
|
(11,111)
|
|
(43,500)
|
|
(40,494)
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to
reconcile loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
142
|
|
132
|
|
557
|
|
481
|
|
Stock-based
compensation
|
|
3,584
|
|
2,416
|
|
13,012
|
|
8,793
|
|
Warrants to service
providers
|
|
197
|
|
82
|
|
629
|
|
354
|
|
Revaluation of warrants
and accretion
|
|
(266)
|
|
(3,361)
|
|
(756)
|
|
(8,122)
|
|
|
|
|
|
|
|
|
|
|
|
Change in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Decrease (increase) in
trade receivable
|
|
508
|
|
(107)
|
|
694
|
|
(2,015)
|
|
Decrease (increase) in
prepaid expenses and other receivables
|
|
(749)
|
|
(348)
|
|
(187)
|
|
1,219
|
|
Operating lease ROU
assets and liabilities, net
|
|
90
|
|
(4)
|
|
86
|
|
(84)
|
|
Increase (decrease) in
trade payables
|
|
549
|
|
(477)
|
|
(103)
|
|
(769)
|
|
Increase (decrease) in
employees and payroll accruals
|
|
396
|
|
775
|
|
55
|
|
(234)
|
|
Decrease in deferred
revenue
|
|
(101)
|
|
-
|
|
(101)
|
|
(375)
|
|
Increase (decrease) in
accrued expenses and other payables
|
|
(110)
|
|
3,001
|
|
(3,899)
|
|
884
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in
operating activities
|
|
(5,045)
|
|
(9,002)
|
|
(33,513)
|
|
(40,362)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
|
Change in bank
deposits
|
|
10,213
|
|
-
|
|
(15,002)
|
|
(400)
|
|
Purchase of property
and equipment
|
|
(59)
|
|
(50)
|
|
(249)
|
|
(918)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) investing activities
|
|
10,154
|
|
(50)
|
|
(15,251)
|
|
(1,318)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance
of ordinary shares, net of issuance costs
|
|
-
|
|
-
|
|
22,496
|
|
-
|
|
Repayment of short-term
loan
|
|
-
|
|
-
|
|
-
|
|
(5,218)
|
|
Proceeds from exercise
of options
|
|
-
|
|
12
|
|
703
|
|
277
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) financing activities
|
|
-
|
|
12
|
|
23,199
|
|
(4,941)
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
fluctuations on cash and cash equivalent
|
|
768
|
|
(616)
|
|
47
|
|
(1,189)
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in
cash, cash equivalents and restricted cash
|
|
4,341
|
|
(8,424)
|
|
(25,612)
|
|
(45,432)
|
|
Cash, cash equivalents
and restricted cash at the beginning of period
|
|
23,641
|
|
63,355
|
|
54,315
|
|
100,936
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash
equivalents and restricted cash at the end of period
|
|
28,750
|
|
54,315
|
|
28,750
|
|
54,315
|
|
RECONCILIATION OF
GAAP NET LOSS TO NON-GAAP NET LOSS
|
(U.S. dollars in
thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
|
December 31,
2023
|
|
December 31,
2022
|
|
December 31,
2023
|
|
December 31,
2022
|
|
GAAP net loss
attributable to ordinary shareholders
|
|
(9,285)
|
|
(11,111)
|
|
(43,500)
|
|
(40,494)
|
|
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
Stock-based
compensation
|
|
3,584
|
|
2,416
|
|
13,012
|
|
8,793
|
|
Warrants to service
providers
|
|
197
|
|
82
|
|
629
|
|
354
|
|
Revaluation of warrants
and accretion
|
|
(266)
|
|
(3,361)
|
|
(756)
|
|
(8,122)
|
|
Non-recurring
expenses
|
|
-
|
|
-
|
|
214
|
|
130
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net
loss
|
|
(5,770)
|
|
(11,974)
|
|
(30,401)
|
|
(39,339)
|
|
|
|
|
|
|
|
|
|
|
|
Basic Non-GAAP net loss
per ordinary share
|
|
(0.07)
|
|
(0.19)
|
|
(0.42)
|
|
(0.62)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing basic Non-
GAAP net loss per ordinary share
|
|
77,837,624
|
|
63,940,247
|
|
72,021,520
|
|
63,489,983
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Non-GAAP net
loss per ordinary share
|
|
(0.10)
|
|
(0.26)
|
|
(0.50)
|
|
(0.78)
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing diluted Non-
GAAP net loss per ordinary share
|
|
63,226,491
|
|
58,860,661
|
|
62,390,302
|
|
60,960,641
|
|
|
|
|
|
|
|
|
|
|
|
RECONCILIATION OF
GAAP NET LOSS TO ADJUSTED EBITDA
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
|
December 31,
2023
|
|
December 31,
2022
|
|
December 31,
2023
|
|
December 31,
2022
|
|
GAAP net loss
attributable to ordinary shareholders
|
|
(9,285)
|
|
(11,111)
|
|
(43,500)
|
|
(40,494)
|
|
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
Financial (income),
net
|
|
(2,812)
|
|
(3,004)
|
|
(3,385)
|
|
(7,237)
|
|
Depreciation
|
|
142
|
|
132
|
|
557
|
|
481
|
|
Stock-based
compensation
|
|
3,584
|
|
2,416
|
|
13,012
|
|
8,793
|
|
Warrants to service
providers
|
|
197
|
|
82
|
|
629
|
|
354
|
|
Non-recurring
expenses
|
|
-
|
|
-
|
|
214
|
|
130
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
(8,174)
|
|
(11,485)
|
|
(32,473)
|
|
(37,973)
|
|
|
|
|
|
|
|
|
|
|
|
View original
content:https://www.prnewswire.com/news-releases/arbe-announces-q4-and-full-year-2023-financial-results-302082916.html
SOURCE Arbe